Global Peptide Therapeutics Sales Market Report 2016

November 2016 | 119 pages | ID: G2D7860CFEEEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Peptide Therapeutics

Revenue, means the sales value of Peptide Therapeutics

This report studies sales (consumption) of Peptide Therapeutics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Amgen
• Roche
• Sanofi
• Takeda Pharmaceutical
• Lonza
• Novartis
• AstraZeneca
• Bachem
• CordenPharma
• Eli Lilly
• Ipsen
• Merck
• Novo Nordisk
• PolyPeptide Group
• Teva

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Peptide Therapeutics in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Generic Peptide Therapeutics
• Branded Peptide Therapeutics
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Peptide Therapeutics in each application, can be divided into

• Cancer
• Cardiovascular
• Central Nervous System
• Metabolic Disorders
• Infection
• Hematological Disorders
• Gastrointestinal Disorders
• Respiratory Disorders
• Acromegaly
• Other Applications

Contents

Global Peptide Therapeutics Sales Market Report 2016

1 PEPTIDE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
  1.2.1 Generic Peptide Therapeutics
  1.2.2 Branded Peptide Therapeutics
  1.2.3 Type III
1.3 Application of Peptide Therapeutics
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 Central Nervous System
  1.3.4 Metabolic Disorders
  1.3.5 Infection
  1.3.6 Hematological Disorders
  1.3.7 Gastrointestinal Disorders
  1.3.8 Respiratory Disorders
  1.3.9 Acromegaly
  1.3.10 Other Applications
1.4 Peptide Therapeutics Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Peptide Therapeutics (2011-2021)
  1.5.1 Global Peptide Therapeutics Sales and Growth Rate (2011-2021)
  1.5.2 Global Peptide Therapeutics Revenue and Growth Rate (2011-2021)

2 GLOBAL PEPTIDE THERAPEUTICS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Peptide Therapeutics Market Competition by Manufacturers
  2.1.1 Global Peptide Therapeutics Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Peptide Therapeutics Revenue and Share by Manufacturers (2011-2016)
2.2 Global Peptide Therapeutics (Volume and Value) by Type
  2.2.1 Global Peptide Therapeutics Sales and Market Share by Type (2011-2016)
  2.2.2 Global Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
2.3 Global Peptide Therapeutics (Volume and Value) by Regions
  2.3.1 Global Peptide Therapeutics Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Peptide Therapeutics Revenue and Market Share by Regions (2011-2016)
2.4 Global Peptide Therapeutics (Volume) by Application

3 UNITED STATES PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Peptide Therapeutics Sales and Value (2011-2016)
  3.1.1 United States Peptide Therapeutics Sales and Growth Rate (2011-2016)
  3.1.2 United States Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  3.1.3 United States Peptide Therapeutics Sales Price Trend (2011-2016)
3.2 United States Peptide Therapeutics Sales and Market Share by Manufacturers
3.3 United States Peptide Therapeutics Sales and Market Share by Type
3.4 United States Peptide Therapeutics Sales and Market Share by Application

4 CHINA PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 China Peptide Therapeutics Sales and Value (2011-2016)
  4.1.1 China Peptide Therapeutics Sales and Growth Rate (2011-2016)
  4.1.2 China Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  4.1.3 China Peptide Therapeutics Sales Price Trend (2011-2016)
4.2 China Peptide Therapeutics Sales and Market Share by Manufacturers
4.3 China Peptide Therapeutics Sales and Market Share by Type
4.4 China Peptide Therapeutics Sales and Market Share by Application

5 EUROPE PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Peptide Therapeutics Sales and Value (2011-2016)
  5.1.1 Europe Peptide Therapeutics Sales and Growth Rate (2011-2016)
  5.1.2 Europe Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Peptide Therapeutics Sales Price Trend (2011-2016)
5.2 Europe Peptide Therapeutics Sales and Market Share by Manufacturers
5.3 Europe Peptide Therapeutics Sales and Market Share by Type
5.4 Europe Peptide Therapeutics Sales and Market Share by Application

6 JAPAN PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Peptide Therapeutics Sales and Value (2011-2016)
  6.1.1 Japan Peptide Therapeutics Sales and Growth Rate (2011-2016)
  6.1.2 Japan Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Peptide Therapeutics Sales Price Trend (2011-2016)
6.2 Japan Peptide Therapeutics Sales and Market Share by Manufacturers
6.3 Japan Peptide Therapeutics Sales and Market Share by Type
6.4 Japan Peptide Therapeutics Sales and Market Share by Application

7 GLOBAL PEPTIDE THERAPEUTICS MANUFACTURERS ANALYSIS

7.1 Amgen
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Peptide Therapeutics Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 119 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Sanofi
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 135 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Takeda Pharmaceutical
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Lonza
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Novartis
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 AstraZeneca
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Bachem
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 CordenPharma
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Eli Lilly
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Ipsen
7.12 Merck
7.13 Novo Nordisk
7.14 PolyPeptide Group
7.15 Teva

8 PEPTIDE THERAPEUTICS MAUFACTURING COST ANALYSIS

8.1 Peptide Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Peptide Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Peptide Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PEPTIDE THERAPEUTICS MARKET FORECAST (2016-2021)

12.1 Global Peptide Therapeutics Sales, Revenue Forecast (2016-2021)
12.2 Global Peptide Therapeutics Sales Forecast by Regions (2016-2021)
12.3 Global Peptide Therapeutics Sales Forecast by Type (2016-2021)
12.4 Global Peptide Therapeutics Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Global Sales Market Share of Peptide Therapeutics by Type in 2015
Figure Generic Peptide Therapeutics Picture
Figure Branded Peptide Therapeutics Picture
Table Applications of Peptide Therapeutics
Figure Global Sales Market Share of Peptide Therapeutics by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure Central Nervous System Examples
Figure Metabolic Disorders Examples
Figure Infection Examples
Figure Hematological Disorders Examples
Figure Gastrointestinal Disorders Examples
Figure Respiratory Disorders Examples
Figure Acromegaly Examples
Figure Other Applications Examples
Figure United States Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure China Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Global Peptide Therapeutics Sales and Growth Rate (2011-2021)
Figure Global Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Table Global Peptide Therapeutics Sales of Key Manufacturers (2011-2016)
Table Global Peptide Therapeutics Sales Share by Manufacturers (2011-2016)
Figure 2015 Peptide Therapeutics Sales Share by Manufacturers
Figure 2016 Peptide Therapeutics Sales Share by Manufacturers
Table Global Peptide Therapeutics Revenue by Manufacturers (2011-2016)
Table Global Peptide Therapeutics Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Peptide Therapeutics Revenue Share by Manufacturers
Table 2016 Global Peptide Therapeutics Revenue Share by Manufacturers
Table Global Peptide Therapeutics Sales and Market Share by Type (2011-2016)
Table Global Peptide Therapeutics Sales Share by Type (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Type (2011-2016)
Figure Global Peptide Therapeutics Sales Growth Rate by Type (2011-2016)
Table Global Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
Table Global Peptide Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Peptide Therapeutics by Type (2011-2016)
Figure Global Peptide Therapeutics Revenue Growth Rate by Type (2011-2016)
Table Global Peptide Therapeutics Sales and Market Share by Regions (2011-2016)
Table Global Peptide Therapeutics Sales Share by Regions (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Regions (2011-2016)
Figure Global Peptide Therapeutics Sales Growth Rate by Regions (2011-2016)
Table Global Peptide Therapeutics Revenue and Market Share by Regions (2011-2016)
Table Global Peptide Therapeutics Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Peptide Therapeutics by Regions (2011-2016)
Figure Global Peptide Therapeutics Revenue Growth Rate by Regions (2011-2016)
Table Global Peptide Therapeutics Sales and Market Share by Application (2011-2016)
Table Global Peptide Therapeutics Sales Share by Application (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Application (2011-2016)
Figure Global Peptide Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure United States Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure United States Peptide Therapeutics Sales Price Trend (2011-2016)
Table United States Peptide Therapeutics Sales by Manufacturers (2011-2016)
Table United States Peptide Therapeutics Market Share by Manufacturers (2011-2016)
Table United States Peptide Therapeutics Sales by Type (2011-2016)
Table United States Peptide Therapeutics Market Share by Type (2011-2016)
Table United States Peptide Therapeutics Sales by Application (2011-2016)
Table United States Peptide Therapeutics Market Share by Application (2011-2016)
Figure China Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure China Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure China Peptide Therapeutics Sales Price Trend (2011-2016)
Table China Peptide Therapeutics Sales by Manufacturers (2011-2016)
Table China Peptide Therapeutics Market Share by Manufacturers (2011-2016)
Table China Peptide Therapeutics Sales by Type (2011-2016)
Table China Peptide Therapeutics Market Share by Type (2011-2016)
Table China Peptide Therapeutics Sales by Application (2011-2016)
Table China Peptide Therapeutics Market Share by Application (2011-2016)
Figure Europe Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Europe Peptide Therapeutics Sales Price Trend (2011-2016)
Table Europe Peptide Therapeutics Sales by Manufacturers (2011-2016)
Table Europe Peptide Therapeutics Market Share by Manufacturers (2011-2016)
Table Europe Peptide Therapeutics Sales by Type (2011-2016)
Table Europe Peptide Therapeutics Market Share by Type (2011-2016)
Table Europe Peptide Therapeutics Sales by Application (2011-2016)
Table Europe Peptide Therapeutics Market Share by Application (2011-2016)
Figure Japan Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Japan Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Japan Peptide Therapeutics Sales Price Trend (2011-2016)
Table Japan Peptide Therapeutics Sales by Manufacturers (2011-2016)
Table Japan Peptide Therapeutics Market Share by Manufacturers (2011-2016)
Table Japan Peptide Therapeutics Sales by Type (2011-2016)
Table Japan Peptide Therapeutics Market Share by Type (2011-2016)
Table Japan Peptide Therapeutics Sales by Application (2011-2016)
Table Japan Peptide Therapeutics Market Share by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Peptide Therapeutics Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Peptide Therapeutics Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Peptide Therapeutics Global Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Peptide Therapeutics Global Market Share (2011-2016)
Table Lonza Basic Information List
Table Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lonza Peptide Therapeutics Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Peptide Therapeutics Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Peptide Therapeutics Global Market Share (2011-2016)
Table Bachem Basic Information List
Table Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bachem Peptide Therapeutics Global Market Share (2011-2016)
Table CordenPharma Basic Information List
Table CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CordenPharma Peptide Therapeutics Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Peptide Therapeutics Global Market Share (2011-2016)
Table Ipsen Basic Information List
Table Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ipsen Peptide Therapeutics Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Peptide Therapeutics Global Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Peptide Therapeutics Global Market Share (2011-2016)
Table PolyPeptide Group Basic Information List
Table PolyPeptide Group Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure PolyPeptide Group Peptide Therapeutics Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Peptide Therapeutics Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders List
Figure Global Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Global Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Global Peptide Therapeutics Sales Forecast by Regions (2016-2021)
Table Global Peptide Therapeutics Sales Forecast by Type (2016-2021)
Table Global Peptide Therapeutics Sales Forecast by Application (2016-2021)